Navigation Links
VCU Massey Cancer Center study shows enzyme linked to spread of breast cancer cells

Researchers at the Virginia Commonwealth University Massey Cancer Center have found a new signaling component that influences movement of human breast cancer cells toward epidermal growth factor.

In the August issue of the Journal of Biological Chemistry, researchers showed that epidermal growth factor, which plays a critical role in breast cancer progression, stimulates sphingosine kinases - SphK1 and SphK2 - a family of enzymes that forms the potent lipid mediator, sphingosine-1-phosphate, and that breast cancer cells are unable to move without these kinases.

"If we understood how tumor cells spread or metastasize, we would be able to design better tools to help treat cancers," said lead author Sarah Spiegel, Ph.D., chair and professor in the VCU Department of Biochemistry and co-leader of the Massey Cancer Center Cell Signaling program.

Spiegel, who is internationally recognized for her pioneering work on new lipid mediators that regulate cell growth and cell death, and her colleagues, first discovered the role of sphingosine-1-phosphate in cell growth regulation nearly a decade ago. While researchers know that SphK1 is stimulated by multiple growth factors, less is known about how SphK2 is regulated. Spiegel and her team are continuing this work to better understand the functions of these enzymes.

"Our work suggests that sphingosine kinases are potential new targets in cancer therapy," she said.


'"/>

Source:Virginia Commonwealth University


Page: 1

Related biology news :

1. Massey Cancer Center researcher helps to identify a piece of the cancer puzzle
2. VCU Massey Cancer Center researchers identify a new class of anti-cancer drugs based on platinum
3. Massey researchers induce cell death in leukemia
4. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
5. Jump-starting T Cells In Skin Cancer
6. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
7. Fox Chase Cancer Center scientists identify immune-system mutation
8. Breakthrough Microarray-based Technology for the Study of Cancer
9. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
10. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
11. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/6/2019)... ... August 06, 2019 , ... A study ... that could have far-reaching implications for personalized medicine, especially when seeking treatments for ... able to predict which stem cell donors and manipulation methods might yield the ...
(Date:8/6/2019)... (PRWEB) , ... August 06, 2019 , ... ... sustainability, and environmental concerns. One plant-based food in particular quickly entered the limelight ... counterparts, product developers use a thermogelling and emulsifying ingredient such as methyl cellulose. ...
(Date:8/1/2019)... , ... August 01, 2019 , ... John R. Freeman, ... Fruehauf, MD, PhD, founder and president of BioLabs, which provides premier co-working spaces for ... role to strengthen our ability to forecast and manage growth,” says Fruehauf. “BioLabs has ...
Breaking Biology News(10 mins):
(Date:7/11/2019)... ... July 11, 2019 , ... At the most recent ... therapies to eight military Veterans under the R3 Heroes Program. The Veterans included individuals ... R3 Heroes Program allow anyone to nominate a military Veteran, teacher or first responder ...
(Date:7/9/2019)... ... July 08, 2019 , ... Balluff ... Indicator was recognized as the 2019 Innovative Product of the Year which highlights ... awards were during Sensors Expo & Conference 2019, held this week ...
(Date:6/26/2019)... , ... June 26, 2019 , ... Alice Branton today ... on improving physicochemical properties of Magnesium Gluconate, which can prove to be beneficial for ... alteration of characteristic differentiation peak, change in crystallite size , Over 142% ...
(Date:6/18/2019)... ... 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived ... for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. The ... This IND is the first of several planned clinical trials which will enable ...
Breaking Biology Technology: